| Jovita Wilson, | |
|
1010 E 10th St, Tucson, AZ 85719-5813 | |
| (708) 368-1562 | |
| Not Available |
| Full Name | Jovita Wilson |
|---|---|
| Gender | Female |
| Speciality | Licensed Vocational Nurse |
| Location | 1010 E 10th St, Tucson, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316582752 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164X00000X | Licensed Vocational Nurse | LP053325 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jovita Wilson, 1010 E 10th St, Tucson, AZ 85719-5813 Ph: () - | Jovita Wilson, 1010 E 10th St, Tucson, AZ 85719-5813 Ph: (708) 368-1562 |
News Archive
CML is caused by the breakage and swapping of chromosomes 9 and 22, which results in a shortened chromosome called the Philadelphia chromosome. Cells with the abnormal chromosome make a protein that encourages aberrant growth and division. Patients with CML can be treated with a drug called imatinib or interferon alfa.
Many public safety-net hospitals are likely to face increasing financial and competitive pressures stemming in part from the recent Supreme Court decision on the Affordable Care Act, according to researchers at Penn State and the Harvard School of Public Health.
"GOP Senate Leader Mitch McConnell, Ky., GOP Senate Whip Jon Kyl, Ariz., Senate Republican Conference Chairman Lamar Alexander, Tenn., and House Republican Conference Chairman Mike Pence, Ind., went on the offensive following Obama's speech in Chicago to the American Medical Association. Kyl and McConnell unveiled a bill to rival the Democratic bill, while Alexander and Pence spoke to reporters," according to the Hill.
ZIOPHARM Oncology, Inc. announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for Application Serial No. 11/257,766 entitled "Salts of Isophosphoramide mustard and analogs thereof as anti-tumor agents" with claims directed to compounds, pharmaceutical compositions, and lyophilisates. These claims cover the Company's proprietary palifosfamide composition (ZIO-201 or ZymafosTM). The Company has recently reported positive randomized Phase II sarcoma interim data for intravenous palifosfamide at the Annual Meeting of the Connective Tissue Oncology Society (CTOS) on November 6, 2009 and expects, following U.S. Food and Drug Administration (FDA) review, to initiate a registration trial the first half of 2010.
› Verified 8 days ago
Mrs. Marcella E Sheriff, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 3601 S 6th Ave, Tucson, AZ 85723 Phone: 520-792-1450 | |
Melissa Hale, LPN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 1010 E 10th St, Tucson, AZ 85719 Phone: 520-225-6060 |